Business
10x Genomics Demonstrates Breadth, Scale and Leadership at 2023 AGBT General Meeting
Showcases unique power and scalability of Chromium Flex across fresh, frozen and FFPE samples, including data from an 8 million cell experiment on a single
About this update from 10x Genomics, Inc.
[{"type":"text","content":"Showcases unique power and scalability of Chromium Flex across fresh, frozen and FFPE samples, including data from an 8 million cell experiment on a single runReinforces performance advantages of Visium CytAssist for unbiased spatial discovery with new data and an exclusive product pipeline, including Visium HDShares technology roadmap for the Xenium platform, including a broader menu of targeted and customizable panels and the future capability to scale to thousands of plexLaunches Xenium Catalyst Program to accelerate researchers' access to high-quality, proof-of-concept in situ dataPLEASANTON, Calif., Feb. 6, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology, today announced a series of new product updates and technology demonstrations that will be presented at the 2023 Advances in Genome Biology and Technology (AGBT) General Meeting this week in Hollywood, Fla. The latest developments include new proof-of-concept data showcasing the company's performance, leadership and innovation at the forefront of single-cell analysis, spatial biology and in situ technology.\n\n \n \n \n \n \n \n\n \n\"2022 was the most exciting year of product launches in 10x history. We're building on our momentum with new capabilities and incredible data demonstrating major advances in each of our three platforms,\" said Ben Hindson, Co-founder and Chief Scientific Officer of 10x Genomics. \"10x is the only company with technologies that cover single cell, spatial and in situ analysis. Whether used independently or as an integrated suite, our highly complementary tools are helping researchers unlock new biological insights that will ultimately advance human health. At AGBT, we're excited to showcase researchers' success with the 10x toolkit and demonstrate the power of our innovation engine to expand the boundaries of scientific research.\"\n10x Genomics will host a workshop at AGBT on Wednesday, February 8, at 1:10 p.m. ET to share the latest data and development directions across its three platforms. This workshop will be live-streamed for researchers not attending AGBT.\nChromium Single Cell Analysis \nBuilding on its track record of innovation, 10x Genomics today announced new capabilities on its market-defining Chromium single cell platform that unlock broader sample access and enable larger...